Cancer Drug Encyclopedia
Approved oncology medications — what they treat, how they work and key safety information.
Advanced solid tumors and hematologic malignancies with matching genomic alterations.
Approved for use in oncology care according to FDA-approved indications.
NTRK gene fusion-positive solid tumors across all tissue origins.
Deleterious BRCA-mutated or HRD-positive Ovarian, Breast, Pancreatic, and Prostate Cancers.
Deleterious BRCA-mutated or HRD-positive Ovarian, Breast, Pancreatic, and Prostate Cancers.
Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, and Multiple Myeloma.
Myelofibrosis, Polycythemia Vera, and acute/chronic Graft-versus-Host Disease (GVHD).
Targeted treatment of solid tumors and hematologic malignancies.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.
Approved for use in oncology care according to FDA-approved indications.